• FirefoxUpgrade to the new Firefox »
  •  Dow Up 1.56% Nasdaq Up 1.67%

    PDL BioPharma, Inc. (PDLI)

    -NasdaqGS
    7.64 Down 0.06(0.82%) 2:30PM EST - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:7.70
    Open:7.83
    Bid:7.63 x 13900
    Ask:7.64 x 5400
    1y Target Est:8.00
    Beta:0.63
    Earnings Date:Mar 2 - Mar 6 (Est.)
    Day's Range:7.57 - 7.85
    52wk Range:7.22 - 10.26
    Volume:1,439,129
    Avg Vol (3m):3,093,240
    Market Cap:1.23B
    P/E (ttm):3.87
    EPS (ttm):1.97
    Div & Yield:0.60 (7.90%)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for PDLI

    Comparison

    Symbol% ChgMkt Cap
    PDLIDown 0.82%1.23B
    AMGNUp 2.20%127.08B
    SGENUp 2.96%4.10B
    XOMADown 2.78%451.05M

    Key Statistics

    Forward P/E (1 yr):3.57
    P/S (ttm):2.66
    Ex-Dividend Date:03-Dec-14

    Analysts

    Annual EPS Est (Dec-14) :2.13
    Quarterly EPS Est (Dec-14) :0.56
    Mean Recommendation*:3.0
    PEG Ratio (5 yr expected):0.25

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    PDL BioPharma, Inc. manages a portfolio of patents and royalty assets. The company is involved in the humanization of monoclonal antibodies and the discovery of a new generation of targeted treatments for cancer and immunologic diseases. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback